Dunn Meadow Specialty Pharmacy

Dunn Meadow Specialty Pharmacy was a national specialty pharmacy based in Fort Lee, New Jersey, that provided high-touch pharmacy services for complex disease states. The company specialized in pain management, oncology, and pulmonology, serving patients across all 50 states with a focus on specialty medication dispensing and prior authorization support. In 2022, Dunn Meadow LLC pleaded guilty to federal charges of conspiring to illegally distribute prescription fentanyl and providing kickbacks to healthcare providers. As part of a comprehensive settlement with the Department of Justice, the company and its parent, Allegheny Pharma LLC, agreed to pay up to $50 million in penalties. The pharmacy ceased its mail-order operations in June 2021 following extensive federal investigations into its dispensing practices and relationships with pharmaceutical manufacturers.